Tonghua Dongbao Plans to Subscribe Up to 162 Million Yuan in Amoytop Biotech Convertible Bonds

Stock News

07/27

Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867) has announced its intention to participate in the subscription of convertible bonds issued by its associate company, Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278).

According to the company's announcement, Amoytop Biotech plans to issue convertible bonds to unspecified investors, with a total fundraising amount not exceeding 1.533 billion yuan. Tonghua Dongbao will exercise its preemptive rights to subscribe for these bonds. The total investment principal for this subscription is capped at 162 million yuan.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1159863253"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1159863253\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1159863253?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-27 16:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159863253","market":"sg","top_or_hot":-1,"title":"Tonghua Dongbao Plans to Subscribe Up to 162 Million Yuan in Amoytop Biotech Convertible Bonds","media":"Stock News","content":"<p><b>Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867)</b> has announced its intention to participate in the subscription of convertible bonds issued by its associate company, <b>Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278)</b>.<br><br>According to the company's announcement, Amoytop Biotech plans to issue convertible bonds to unspecified investors, with a total fundraising amount not exceeding 1.533 billion yuan. Tonghua Dongbao will exercise its preemptive rights to subscribe for these bonds. The total investment principal for this subscription is capped at 162 million yuan.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tonghua Dongbao Plans to Subscribe Up to 162 Million Yuan in Amoytop Biotech Convertible Bonds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTonghua Dongbao Plans to Subscribe Up to 162 Million Yuan in Amoytop Biotech Convertible Bonds\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-07-27 16:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867)</b> has announced its intention to participate in the subscription of convertible bonds issued by its associate company, <b>Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278)</b>.<br><br>According to the company's announcement, Amoytop Biotech plans to issue convertible bonds to unspecified investors, with a total fundraising amount not exceeding 1.533 billion yuan. Tonghua Dongbao will exercise its preemptive rights to subscribe for these bonds. The total investment principal for this subscription is capped at 162 million yuan.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688278","symbol_name":"特宝生物","start_time":0,"source_url":"","article_id":"1159863253","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159863253","pubTimestamp":1785139464,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867) has announced its intention to participate in the subscription of convertible bonds issued by its associate company, Xiamen Amoytop Biotech Co.,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600867":"通化东宝","688278":"特宝生物","BK0188":"融资融券","BK0196":"行业龙头","FCEF":"First Trust Income Opportunities ETF","BK0239":"医药制造","SABA":"Saba Capital Income & Opportunities Fund II"},"translate_title":"通化东宝计划认购至多1.62亿元的Amoytop生物可转换债券","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600867":1,"688278":1,"SABA":1,"FCEF":1},"content_text":"Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867) has announced its intention to participate in the subscription of convertible bonds issued by its associate company, Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278).According to the company's announcement, Amoytop Biotech plans to issue convertible bonds to unspecified investors, with a total fundraising amount not exceeding 1.533 billion yuan. Tonghua Dongbao will exercise its preemptive rights to subscribe for these bonds. The total investment principal for this subscription is capped at 162 million yuan.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}